Apeloa Pharmaceutical Co.,Ltd
000739
Rank in Stocks
#4306
Apeloa Pharmaceutical Co.,Ltd operates as a comprehensive pharmaceutical... Apeloa Pharmaceutical Co.,Ltd operates as a comprehensive pharmaceutical enterprise, specializing in the discovery, development, production, and global distribution of a diverse range of medicinal products. Its market reach spans China and various international territories. The company strategically focuses its product portfolio on several critical medical fields, including cardiovascular and cerebrovascular health, anti-infective treatments, antiviral therapies, and oncology (cancer treatment), alongside other therapeutic categories. Apeloa's offerings encompass finished pharmaceutical preparations, raw material intermediates (active pharmaceutical ingredients and their precursors), and veterinary medicines. These products are primarily recognized and sold under key brands such as Tianliwei, Beshin, Yosemade, and Jutai, among others. Furthermore, the company extends its expertise to other pharmaceutical businesses by providing contract research, development, and manufacturing (CDMO) services. The corporate headquarters for Apeloa Pharmaceutical Co.,Ltd are located in Dongyang, China.
Share Price
$3.17
Last synced: 2026-10-21
Market Cap
$3.67B
Change (1 day)
0.76%
Change (1 year)
48.70%
Country
CN
Trade Apeloa Pharmaceutical Co.,Ltd (000739)
Category
Healthcare
Number of shares outstanding for Apeloa Pharmaceutical Co.,Ltd (000739)
Number of shares outstanding as of June 2026: 1.13B
According to Apeloa Pharmaceutical Co.,Ltd latest financial reports and stock price the company's current number of shares outstanding is 1.13B. At the end of December 2023 the company had 1.17B shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Apeloa Pharmaceutical Co.,Ltd (000739) from 2000 to 2026
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2026 (TTM) | 1.13B | -2.53% |
| 2024 | 1.16B | -0.93% |
| 2023 | 1.17B | 0.00% |
| 2022 | 1.17B | -0.78% |
| 2021 | 1.18B | 0.00% |
| 2020 | 1.18B | 0.00% |
| 2019 | 1.18B | 0.00% |
| 2018 | 1.18B | 2.52% |
| 2017 | 1.15B | 0.58% |
| 2016 | 1.14B | -0.33% |
| 2015 | 1.15B | 6.80% |
| 2014 | 1.07B | 34.75% |
| 2013 | 796.95M | 63.70% |
| 2012 | 486.82M | -49.99% |
| 2011 | 973.47M | 41.65% |
| 2010 | 687.25M | 2.98% |
| 2009 | 667.33M | -0.02% |
| 2008 | 667.43M | 5.15% |
| 2007 | 634.73M | 11.69% |
| 2006 | 568.31M | -10.46% |
| 2005 | 634.73M | 0.00% |
| 2004 | 634.73M | 0.00% |
| 2003 | 634.73M | 0.00% |
| 2002 | 634.73M | 0.00% |
| 2001 | 634.73M | 0.00% |
| 2000 | 634.73M | 0.00% |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | 112.49% |
IN
|
